Answers are grounded in this paper and cite their sources.
Adherence in clinical trials is a consistent problem regardless of the disease process or organ system under investigation. In this paper data and examples from clinical trials examining cardiovascular diseases are used as the basis for a review of various adherence principles. Issues reviewed include: the importance of adherence in clinical trials, an overall program for adherence in clinical trials, and specific issues in adherence from arthritis clinical trials. Special attention is given to a program for the prevention of reduced adherence for participants of a clinical trial as well as acute and chronic intervention plans for those with good adherence and those with reduced adherence in a clinical trial.
No takes yet. Share an insight, caveat, or question.
Jeffrey L. Probstfield (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: